← Scroll for more →
Xilio Therapeutics, Inc. (XLO)
Pharmaceutical Preparations
Latest Price
$8.01
TTM P/E
--
Normalized P/E
0.75
TTM Div Yield
--
Fwd Div Yield
--
Book Value
4.04
P/B Ratio
1.98
Institutional Ownership
41.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 664.0K | $6.0M | 10.09% | -- | 2026-06-30 |
| Orbimed Advisors LLC | 592.3K | $5.0M | 9.00% | -- | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 422.5K | $4.0M | 6.42% | -- | 2026-06-30 |
| Stonepine Capital Management, LLC | 226.0K | $2.0M | 3.43% | +161.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 178.5K | $1.0M | 2.71% | +54.9K | 2026-06-30 |
| Sio Capital Management, LLC | 152.5K | $1.0M | 2.32% | -- | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 111.5K | $1.0M | 1.70% | -- | 2026-06-30 |
| Merck & Co., Inc. | 106.0K | $1.0M | 1.61% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 64.2K | -- | 0.97% | +14.6K | 2026-06-30 |
| Morgan Stanley | 57.0K | -- | 0.87% | -539 | 2026-06-30 |